PRMT5 inhibition drives therapeutic vulnerability to combination treatment with BCL-2 inhibition in mantle cell lymphoma
- Resource Type
- Article
- Authors
- Brown-Burke, Fiona; Hwang, Inah; Sloan, Shelby; Hinterschied, Claire; Helmig-Mason, JoBeth; Long, Mackenzie; Chan, Wing Keung; Prouty, Alexander; Chung, Ji-Hyun; Zhang, Yang; Singh, Satishkumar; Youssef, Youssef; Bhagwat, Neha; Chen, Zhengming; Chen-Kiang, Selina; Di Liberto, Maurizio; Elemento, Olivier; Sehgal, Lalit; Alinari, Lapo; Vaddi, Kris; Scherle, Peggy; Lapalombella, Rosa; Paik, Jihye; Baiocchi, Robert A.
- Source
- In Blood Advances 24 October 2023 7(20):6211-6224
- Subject
- Lymphoid Neoplasia
- Language
- ISSN
- 2473-9529